Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Selby

Showing results (111-120 of 316) with videos related to

Pageof 32
Sort By:
Annals of Clinical Biochemistry|March 4, 2011
Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ionsTobias C Wind, Michael P Messenger, Douglas Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapyM J Tilby, D R Newell, C Viner, et al.
British Journal of Cancer|July 1, 1978
Growth of human tumour cell colonies from biopsies using two soft-agar techniquesV D Courtenay, P J Selby, I E Smith, et al.
BMJ Open|February 24, 2026
Digital patient decision aids for endometriosis management: a scoping review protocolOcéane Pittet, Marion Delvallée, Nicola Pluchino, et al.
Obstetrics and Gynecology|May 1, 1994
Cyclic hormone replacement therapy using quarterly progestinB Ettinger, J Selby, J T Citron, et al.
Lancet (London, England)|February 27, 1988
Endogenous tumour necrosis factor in cancer patientsP J Selby, S Hobbs, C Viner, et al.
British Journal of Cancer|September 1, 1980
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapyP J Selby, V D Courtenay, T J McElwain, et al.
International Journal of Cancer|May 31, 2007
CD40-mediated death and cytokine secretion in colorectal cancer: a potential target for inflammatory tumour cell killingNikolaos T Georgopoulos, Alison Merrick, Nigel Scott, et al.
Gut|August 1, 1990
Tumour necrosis factor, cholestatic jaundice, and chronic liver diseaseA Jones, P J Selby, C Viner, et al.
British Journal of Cancer|May 1, 1987
Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapyP J Selby, N Lopes, J Mundy, et al.
Pageof 32

Showing results (111-120 of 316) with videos related to

Sort By:
Pageof 32
Annals of Clinical Biochemistry|March 4, 2011
Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ionsTobias C Wind, Michael P Messenger, Douglas Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapyM J Tilby, D R Newell, C Viner, et al.
British Journal of Cancer|July 1, 1978
Growth of human tumour cell colonies from biopsies using two soft-agar techniquesV D Courtenay, P J Selby, I E Smith, et al.
BMJ Open|February 24, 2026
Digital patient decision aids for endometriosis management: a scoping review protocolOcéane Pittet, Marion Delvallée, Nicola Pluchino, et al.
Obstetrics and Gynecology|May 1, 1994
Cyclic hormone replacement therapy using quarterly progestinB Ettinger, J Selby, J T Citron, et al.
Lancet (London, England)|February 27, 1988
Endogenous tumour necrosis factor in cancer patientsP J Selby, S Hobbs, C Viner, et al.
British Journal of Cancer|September 1, 1980
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapyP J Selby, V D Courtenay, T J McElwain, et al.
International Journal of Cancer|May 31, 2007
CD40-mediated death and cytokine secretion in colorectal cancer: a potential target for inflammatory tumour cell killingNikolaos T Georgopoulos, Alison Merrick, Nigel Scott, et al.
Gut|August 1, 1990
Tumour necrosis factor, cholestatic jaundice, and chronic liver diseaseA Jones, P J Selby, C Viner, et al.
British Journal of Cancer|May 1, 1987
Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapyP J Selby, N Lopes, J Mundy, et al.
Pageof 32